![]() |
市场调查报告书
商品编码
1662605
2030 年奈米乳剂市场预测:按类型、成分、製备方法、稳定性、给药途径、应用和地区进行的全球分析Nanoemulsion Market Forecasts to 2030 - Global Analysis By Type (Oil-in-Water Nanoemulsion, Water-in-Oil Nanoemulsion and Bi-Continuous Nanoemulsion), Composition, Preparation Method, Stability, Route of Administration, Application and By Geography |
根据 Stratistics MRC 的数据,全球奈米乳液市场预计在 2024 年达到 128.4 亿美元,到 2030 年将达到 201.7 亿美元,预测期内的复合年增长率为 9.2%。
乳化是一种由细分散液滴组成的乳化系统,液滴尺寸通常在 20 至 200 奈米之间。这些系统是透明或半透明的并且动态稳定。描述了一种用于配製能够同时携带亲水性和亲油性化合物并且与传统乳化相比具有更佳性能和稳定性的产品的多功能解决方案。
根据 News-Medical.Net 2020 年 9 月的一篇研究报导,研究人员表示,奈米乳剂系统可以诱发与减毒活病毒疫苗类似的免疫反应,但没有復发的风险。
护肤和抗衰老产品需求增加
乳化增强维生素、抗氧化剂和胜肽等活性成分的渗透和吸收。这些成分可以深入皮肤,提高产品的功效并增强其抗衰老功效。此外,乳化还具有更高的稳定性、更长的保质期以及製造更轻、不油腻配方的能力,所有这些都吸引了寻求更有效和创新的护肤解决方案的消费者。这种需求推动了奈米乳液技术在化妆品行业的应用。
稳定性问题
乳化的稳定性问题是由于颗粒聚集、相分离和聚结等因素引起的,这些因素可能随着时间的推移和在某些储存条件下发生。这些问题通常是由配方不当、高能量需求或温度波动或 pH 值变化等外部因素引起的。这种不稳定性限制了奈米乳液产品的保质期和功效,尤其是在药品和化妆品中,从而阻碍了市场的成长。
药品需求不断成长
乳化是有效传递活性药物成分的理想选择,因为它们可以提高水溶性差的药物的生物有效性、稳定性和溶解度。特别是随着标靶治疗、疫苗和生技药品等新型製剂的持续研究,乳化代表了改善药物吸收和控制释放的一种有希望的解决方案。慢性病的增加、个人化医疗以及对更安全、更有效的药物传递系统的需求进一步推动了奈米乳剂技术在製药领域的应用,从而推动了市场的成长。
製造成本高
乳化的生产成本很高,因为它们需要专门的设备、先进的原料和复杂的製造过程来精确控制液滴的大小和稳定性。高压均质化和微流体化等技术导致成本上升。此外,确保一致性、可扩展性和法规遵循会带来越来越大的经济负担。这种成本上升可能会限制市场可近性,从而阻碍市场成长,尤其是对于中小型企业而言。
COVID-19 的影响
COVID-19 疫情以多种方式影响了奈米乳液市场。从积极的一面来看,疫苗输送系统、抗病毒药物和个人防护产品等药物应用对奈米乳液的需求增加。消毒剂、消毒剂和护肤品的需求激增也促进了市场的发展。然而,供应链中断、製造延迟以及研发活动低迷阻碍了成长。儘管存在这些挑战,但由于对先进药物输送系统的需求不断增长,市场表现出了韧性。
预计油包水奈米乳液市场在预测期内将占据最大份额
预计在整个预测期内,油包水奈米乳液将占据最大的市场占有率。油包水乳化乳化一种将微小的油滴分散在水相中的乳液,油滴尺寸通常在 20 至 200 奈米范围内。这种乳化广泛应用于药品、化妆品和食品。油包水乳化具有更高的稳定性、更低的毒性和控制释放,使其成为药物传输系统、护肤产品和机能性食品配方的理想选择。
预计预测期内食品和饮料产业将以最高的复合年增长率成长。
预计预测期内食品和饮料产业将以最高的复合年增长率成长。在食品和饮料工业中,乳化用于改善风味、营养成分和生物活性化合物的传输。乳化可有效用于强化饮料、机能性食品和调味品等产品,因为它们可以提高维生素、抗氧化剂和精油等成分的稳定性、溶解度和吸收率。提供始终如一的品质并维持乳液不分离的能力正在推动该领域的创新。
由于对先进药物输送系统、个人保健产品以及食品和饮料应用的需求不断增加,预计亚太地区将在预测期内占据最大的市场占有率。中国、印度和日本等国家是主要贡献者,这得益于其製药、化妆品和营养保健品产业的扩张。该地区不断提高的医疗意识以及对生物技术和奈米技术的投资不断增加,正在支持市场扩张。此外,化妆品和食品领域对环保和永续产品的需求正在刺激该地区采用乳化。
由于药物输送系统、製药和化妆品行业的进步,预计北美在预测期内将实现最高的复合年增长率。由于对创新药物製剂(包括疫苗和生技药品)的需求不断增长,美国是该市场的主要参与企业。该地区受益于强劲的研发活动、技术进步和完善的医疗保健基础设施。此外,消费者对化妆品和食品领域的环保和永续配方的需求不断增加,进一步推动了北美对奈米乳液技术的应用。
According to Stratistics MRC, the Global Nanoemulsion Market is accounted for $12.84 billion in 2024 and is expected to reach $20.17 billion by 2030 growing at a CAGR of 9.2% during the forecast period. A nanoemulsion is a type of emulsified system consisting of finely dispersed droplets of one liquid in another, typically with droplet sizes ranging from 20 to 200 nanometers. These systems are transparent or translucent and are thermodynamically stable. They can carry both hydrophilic and lipophilic compounds, offering a versatile solution for formulating products with improved performance and stability compared to traditional emulsions.
According to a research article by News-Medical.Net, in September 2020, researchers stated that nanoemulsion systems can produce immune responses that are similar to live attenuated vaccines but do not run the risk of reversion.
Increasing demand for skincare and anti-aging products
Nanoemulsions provide enhanced penetration and absorption of active ingredients like vitamins, antioxidants, and peptides, which are key components in skincare formulations. Their ability to deliver these ingredients deeper into the skin improves product efficacy and provides better results for anti-aging benefits. Additionally, nanoemulsions offer improved stability, extended shelf life, and the ability to create lightweight, non-greasy formulations, all of which appeal to consumers seeking more effective, innovative skincare solutions. This demand boosts the adoption of nanoemulsion technology in the cosmetics industry.
Stability issues
Stability issues in nanoemulsions arise due to factors like particle aggregation, phase separation, and coalescence, which can occur over time or under specific storage conditions. These issues are often caused by improper formulation, high energy requirements, or external factors like temperature fluctuations and pH changes. Such instability hampers the market growth by limiting the shelf life and effectiveness of nanoemulsion-based products, particularly in pharmaceuticals and cosmetics.
Growing demand in pharmaceuticals
Nanoemulsions enhance the bioavailability, stability, and solubility of poorly water-soluble drugs, making them ideal for delivering active pharmaceutical ingredients effectively. With increasing research into novel formulations, particularly in targeted therapies, vaccines, and biologics, nanoemulsions offer a promising solution for improved drug absorption and controlled release. The rise in chronic diseases, personalized medicine, and the need for safer, more efficient drug delivery systems further boosts the adoption of nanoemulsion technology in the pharmaceutical sector, fueling market growth.
High production costs
Nanoemulsion requires high production costs due to the need for specialized equipment, advanced raw materials, and complex manufacturing processes to achieve precise control over droplet size and stability. Techniques such as high-pressure homogenization and microfluidization contribute to increased costs. Additionally, ensuring consistency, scalability, and regulatory compliance adds financial burdens. These elevated costs can hamper market growth by limiting accessibility, especially for small and medium-sized enterprises.
Covid-19 Impact
The covid-19 pandemic had a mixed impact on the nanoemulsion market. On the positive side, there was increased demand for nanoemulsions in pharmaceuticals for vaccine delivery systems, antivirals, and personal protective products. The surge in demand for sanitizers, disinfectants, and skin-care products also boosted the market. However, disruptions in supply chains, manufacturing delays, and a slowdown in R&D activities during lockdowns hindered growth. Despite these challenges, the market showed resilience due to the growing need for advanced drug delivery systems.
The oil-in-water nanoemulsion segment is expected to be the largest during the forecast period
The oil-in-water nanoemulsion segment is predicted to secure the largest market share throughout the forecast period. Oil-in-water nanoemulsions are emulsions where tiny droplets of oil are dispersed in a water phase, typically with droplet sizes ranging from 20 to 200 nanometers. This type of nanoemulsion is widely used in pharmaceuticals, cosmetics, and food products. Oil-in-water nanoemulsions offer improved stability, reduced toxicity, and controlled release of active ingredients, making them ideal for drug delivery systems, skincare products, and functional food formulations.
The food & beverages segment is expected to have the highest CAGR during the forecast period
The food & beverages segment is anticipated to witness the highest CAGR during the forecast period. In the Food & Beverages industry, nanoemulsions are used to improve the delivery of flavours, nutrients, and bioactive compounds. They enhance the stability, solubility, and absorption of ingredients like vitamins, antioxidants, and essential oils, making them more effective in products like fortified drinks, functional foods, and flavouring agents. Their ability to deliver consistent quality and maintain emulsions without separation drives innovation in the sector.
Asia Pacific is expected to register the largest market share during the forecast period due to the increasing demand for advanced drug delivery systems, personal care products, and food & beverage applications. Countries like China, India, and Japan are major contributors, driven by expanding pharmaceutical, cosmetic, and nutraceutical industries. The region's rising healthcare awareness, along with growing investments in biotechnology and nanotechnology, supports market expansion. Additionally, the demand for eco-friendly, sustainable products in cosmetics and food sectors is fueling the adoption of nanoemulsions in the region.
North America is expected to witness the highest CAGR over the forecast period driven by advancements in drug delivery systems, pharmaceuticals, and the cosmetic industry. The U.S. is a key market player, with rising demand for innovative drug formulations, including vaccines and biologics. The region benefits from robust R&D activities, technological advancements, and a well-established healthcare infrastructure. Additionally, increasing consumer demand for eco-friendly and sustainable formulations in both cosmetics and food sectors is further boosting the adoption of nanoemulsion technologies in North America.
Key players in the market
Some of the key players profiled in the Nanoemulsion Market include AbbVie Inc., AstraZeneca, Allergan, Sanofi, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson, Amgen Inc., Merck & Co., Inc., Bayer AG, Eli Lilly and Company, Hoffmann-La Roche Limited, Takeda Pharmaceutical Company Limited, OrganiGram Holdings Inc., Teva Pharmaceutical Industries Limited, Bausch Health Companies Inc., Lupin Pharmaceuticals, Inc., Cipla Limited, Sun Pharmaceutical Industries Limited and Boehringer Ingelheim.
In November 2024, Organigram has introduced FAST(TM) Nanoemulsion Gummies, an innovative addition to their product line-up. These gummies leverage advanced nanoemulsion technology to offer rapid onset of effects compared to traditional cannabis edibles. Each gummy contains an accurately measured dose of cannabinoids, catering to both new and experienced users looking for predictable results.
In July 2024, Lupin Limited has partnered with Huons Co. Ltd., a South Korea-based pharmaceutical firm, to introduce Cyclosporine Ophthalmic Nanoemulsion in the Mexican market. This innovative product is designed to treat chronic dry eye syndrome, providing enhanced bioavailability and prolonged therapeutic effects due to its nanoemulsion-based formulation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.